MyWay – Patient Support
Personalized treatment support
Only for iPhone
Free
iPhone
Sanofi US is distributing this app on behalf of Sanofi and Regeneron Pharmaceuticals, Inc.
See full Prescribing Information and Patient Information for DUPIXENT® (dupilumab)
https://www.regeneron.com/downloads/dupixent_fpi.pdf
https://www.regeneron.com/downloads/dupixent_ppi.pdf
Personalized support for your treatment journey.
The MyWay app is a patient support tool designed to help you access DUPIXENT® (dupilumab) as quickly as possible, once you have a prescription, and to help you through your treatment journey. The app provides patient support program services, medication tracking, tools, and educational resources to help you stay on track with therapy, including:
Upcoming dose calendar
Healthcare Provider (HCP) visit calendar
Support documentation exchange with Dupixent MyWay patient support program services
Localized environment data
TREATMENT
Insurance help through Dupixent MyWay patient support program services (benefit verification)
Financial assistance for eligible patients (copay card, utilization tracker)
Nurse resource (supplemental injection training)
Medication track (reminder features, step-by-step injection instructions)
Body map tracking and injection completion log
Refill reminders
Other medication reminders
JOURNAL
Symptom tracking journal
Personalized symptom report to share with your doctor
LEARNING
Patient materials (testimonial videos)
SEPTEMBRE 2024 US.DUP.24.09.0167
This version includes functional updates.
The developer, Sanofi Winthrop Industrie, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Linked to You
The following data may be collected and linked to your identity:
- Health & Fitness
- Financial Info
- Location
- Contact Info
- User Content
- Identifiers
- Usage Data
- Sensitive Info
- Diagnostics
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Contact Info
- Search History
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Sanofi Winthrop Industrie
- Size
- 95.6 MB
- Category
- Medical
- Compatibility
Requires iOS 16.0 or later.
- iPhone
Requires iOS 16.0 or later.
- iPhone
- Languages
English and 3 more
- English, Arabic, German, Japanese
- Age Rating
18+
- 18+
- Frequent
Medical Treatment information
Contains
Health or Wellness Topics
- Medical Device
Yes
- Sanofi Winthrop Industrie indicated this app is a regulated medical device and complies with United States law.
- The information below has not been verified by Apple.
- FDA Owner/Operator Number
- 10088901
- Address
- 82 avenue Raspail
94250 Gentilly
France - Phone Number
- +33 6 38 99 42 63
- developer-sanofi-public@sanofi.com
- Use Statement
- Indications For Use:
The Dupixent Digital Companion is a mobile application indicated for use by patients aged 18+ who use Dupixent.
Intended Use:
The Dupixent Digital Companion is a mobile application for use by patients aged 18+ who use Dupixent. The app is intended to provide information for the conditions Dupixent is indicated for and to provide general information regarding living well with the chronic condition and using Dupixent (in alignment with Dupixent labeling). The app can record and provide reminders for administration of Dupixent. - Safety Information
- For any adverse events, users contact 1-844-387-4936
- Instructions for Use
- Visit the developer site
- Copyright
- Sanofi US Services ©2024 Sanofi. All Rights Reserved. Except content specifically related to DUPIXENT® ©2024 Sanofi & Regeneron Pharmaceuticals Inc. All Rights Reserved.